A closer look at the technologies used by Trulicity
Trulicity
Manufacturing · United States · <25 Employees
View Company Info for Free
About
Headquarters
United StatesWebsite
www.trulicity.comRevenue
<$5 MillionIndustry
Recent News & Media
Who is Trulicity
Is Trulicity your ideal customer?
Let us give you the heads up on whether it's a good time to reach out
Check if Trulicity has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Trulicity launches new products
Check out if Trulicity is spiking on competitors!
Funding: Get notified immidiatlly once Trulicity has new funding data
Earning: See what the market has to say on Trulicity recently announced quarterly report
Click to see if Trulicity had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Trulicity
Trulicity, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Trulicity
Find 3 more new buyers
Compare Similar Companies to Trulicity
Compare insights from companies similar to Trulicity, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Trulicity Employee Growth Rate
Percentage of growth
1st year Mask
2nd year Mask
Trulicity Tech Stack
Most Recent Scoops
Trulicity News & Media
Cipla to sell Eli Lilly's insulin products Humalog, Trulicity in India
Only 3 firms - Novo Nordisk, Sanofi, and Eli Lilly - supply insulin to patients in the US. These three companies, commonly called the 'Big Three', control over 90 per cent of the global insulin marketTrulicity® (dulaglutide) is the first and only type 2 diabetes medicine approved to reduce cardiovascular events in adults with and without established cardiovascular disease
The U.S. Food and Drug Administration (FDA) has approved Trulicity® (dulaglutide) for the reduction of major adverse cardiovascular events (MACE) in adults with type 2 diabetes who have established cardiovascular (CV) disease or multiple cardiovascular risk factors. This decision makes Eli Lilly and Company's (NYSE: LLY) Trulicity the first and only type 2 diabetes medicine approved to reduce the risk of MACE for both primary and secondary prevention populations.*
Top Companies in United States
Top 10 companies in United States by revenue
Top 10 companies in United States by number of employees
Top 10 companies in United States by total funding amount
Frequently Asked Questions Regarding Trulicity
Onceweekly Trulicity is a type 2 diabetes medication that helps your body release its own insulin and can help improve your A1C and blood sugar numbers. For people living with T2DM, Trulicity lowers the risk of CV events like heart attack, stroke and CV death in people with known heart disease or multiple risk factors.... Read More